Clinical trial · Interventional
How Easy-to-Follow Exercises Can Help Cancer Patients With Anxiety While Receiving Chemotherapy
The Effect of Mild Exercise While Receiving Chemotherapy on the Psychology of the Cancer Patient
NCT06943638CI-TRIAL-00092939completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Cancer is one of the main causes of death, and this study looks at how light exercise and stretching might reduce anxiety in patients receiving chemotherapy. The research took place in a hospital's daily care unit and used a study design where each patient was compared to themselves, measuring anxiety before and after the exercise program.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Exercise | — | UNRESOLVED | — |
| Stress | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mild Exercise and stretches | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Mild exercise and stretching
- description
- They received individualized workout and stretching programme to relieve some of the stress
- interventionNames
- Other: Mild Exercise and stretches
Primary outcomes (1)
- measure
- The Change in the Anxiety Assessment Scale (STAI-State) for Cancer Patients Receiving Chemotherapy Doing Mild Exercises and Stretches
- timeFrame
- Baseline and approximately 20 minutes post-intervention
- description
- The STAI-State (Greek version, State-Trait Anxiety Inventory -STAI-) will be used to assess anxiety levels in cancer patients undergoing chemotherapy, before and after a brief exercise intervention. The STAI-State scale has a 20-item questionnaire where individuals rate how they feel at a particular moment on a scale from "not at all" to "very much so." "Not at all" equal to 1, "Somewhat" to 2, "Moderately so" to 3, "Very much so" to 4. Scores are submitted and range from 20 to 80, with higher scores indicating greater anxiety. No subscale is required to compute At baseline (Time = 0 minutes), participants complete the STAI-State scale. They then engage in a 15-minute mild exercise and stretching program tailored to their physical condition. In some cases, particularly among younger participants, the session may be conducted in small groups of up to 2 individuals. Immediately post-intervention (approximately 20 minutes from baseline), participants complete the STAI-State scale again.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients (\>18 years old) with cancer receiving chemotherapy * Signed patient consent Exclusion Criteria: * The denial of the patient * The occurrence of side effects from the treatment (such as dizziness, nausea, severe fatigue) * Patients with low cognitive level where they could not follow simple instructions * Patients with hearing disorders that prevented them from following simple instructions * Patients who could not mobilize independently.
References
Publications (2)
- BACKGROUNDFurmaniak AC, Menig M, Markes MH. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. 2016 Sep 21;9(9):CD005001. doi: 10.1002/14651858.CD005001.pub3. PMID 27650122
- BACKGROUNDSchmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL; American College of Sports Medicine. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010 Jul;42(7):1409-26. doi: 10.1249/MSS.0b013e3181e0c112. PMID 20559064